Di Martile, M., Desideri, M., Tupone, M. G., Buglioni, S., Antoniani, B., Mastroiorio, C., . . . Del Bufalo, D. (2018). Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma. Oncogenesis.
Chicago Style aipamenaDi Martile, Marta, et al. "Histone Deacetylase Inhibitor ITF2357 Leads to Apoptosis and Enhances Doxorubicin Cytotoxicity in Preclinical Models of Human Sarcoma." Oncogenesis 2018.
MLA aipamenaDi Martile, Marta, et al. "Histone Deacetylase Inhibitor ITF2357 Leads to Apoptosis and Enhances Doxorubicin Cytotoxicity in Preclinical Models of Human Sarcoma." Oncogenesis 2018.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.